pcDNA3.3_OCT4 Citations (3)

Originally described in: Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA.
Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ Cell Stem Cell. 2010 Sep 29. ():. PubMed Journal

---

Articles Citing pcDNA3.3_OCT4

Articles
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G. Oncogene. 2014 Nov 13;33(46):5319-31. doi: 10.1038/onc.2013.476. Epub 2013 Nov 18. PubMed
Stem cell markers in glioma progression and recurrence. Hattermann K, Fluh C, Engel D, Mehdorn HM, Synowitz M, Mentlein R, Held-Feindt J. Int J Oncol. 2016 Nov;49(5):1899-1910. doi: 10.3892/ijo.2016.3682. Epub 2016 Sep 6. PubMed
High-efficiency RNA-based reprogramming of human primary fibroblasts. Kogut I, McCarthy SM, Pavlova M, Astling DP, Chen X, Jakimenko A, Jones KL, Getahun A, Cambier JC, Pasmooij AMG, Jonkman MF, Roop DR, Bilousova G. Nat Commun. 2018 Feb 21;9(1):745. doi: 10.1038/s41467-018-03190-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.